A61K 31/503
Spiro-condensed
Official title: spiro-condensed
A61K31/503 (Spiro-condensed) appears on 52 US grants and 45 published applications in this corpus.
Search patents in A61K- Granted patents
- 52
- Published applications
- 45
- Assignees
- 28
- Inventors
- 141
- Latest grant
- 24 Jan 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 9 | 0 |
| 1999 | 10 | 0 |
| 2000 | 6 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 8 |
| 2004 | 2 | 7 |
| 2005 | 3 | 7 |
| 2006 | 2 | 7 |
| 2007 | 1 | 3 |
| 2008 | 6 | 2 |
| 2009 | 1 | 2 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 3 | 3 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Compositions and formulations for treatment of malignancies24 Jan 2023US 11,559,500 B2Neugate Pharma, LLC
- Antiviral compounds and uses thereof2 May 2017US 9,637,478 B2AbbVie Inc.
- Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same22 Nov 2016US 9,499,553 B2Chugai Seiyaku Kabushiki Kaisha
- Anti-inflammatory pharmaceutical composition comprising benzopyranyl tetracycles18 Oct 2016US 9,468,641 B2Kyungpook National University Hospital
- Antiviral compounds and uses thereof31 May 2016US 9,353,091 B2AbbVie Inc.
- Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds24 Jul 2025US 2025/0235460 A1Pfizer Inc.
- Compositions and formulations for treatment of malignancies22 Oct 2020US 2020/0330398 A1Neugate Pharma, LLC aka Neugate Theranostics
- Antiviral compounds and uses thereof22 Dec 2016US 2016/0368905 A1AbbVie Inc.
- Anti-inflammatory pharmaceutical composition comprising benzopyranyl tetracycles11 Feb 2016US 2016/0038489 A1Kyungpook National University Hospital
- Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same7 Jan 2016US 2016/0002251 A1Chugai Seiyaku Kabushiki Kaisha
Most cited
By later US patents
- Compositions comprising hyaluronic acid and drugs122US 5,985,850 AHyal Pharmaceuticals Corporation · 1999
- Fused-ring compounds and use thereof as drugs67US 7,112,600 B1Japan Tobacco Inc. · 2006
- Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents49US 6,069,135 AHyal Pharmaceutical Corporation · 2000
- Use of hyaluronic acid and forms to prevent arterial restenosis46US 6,022,866 AHyal Pharmaceutical Corporation · 2000
- Topical composition containing hyaluronic acid and NSAIDS45US 5,824,658 AHyal Pharmaceutical Corporation · 1998